Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Business and Regulatory News
Nature Biotechnology 20, 1065–1066 (1 November 2002) | doi:10.1038/nbt1102-1065b
Biotechs hold their own in shifting industry
Abstract
Investors' confidence in the big drug companies is being badly shaken by the widening rift between the pharmaceutical industry and the biotech sector, according to industry analysts. The changed landscape is tempting more biotechnology firms to steer clear of what may turn out to be unprofitable partnerships with the large-cap pharmaceutical sector—provided they have the cash.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
